OBJECTIVE To study the synthesis of chiral precursor R(-)-mandelic acid obtained by asymmetric bioreduction of phenylglyoxylic acid.METHODS Saccharomyces cerevisiae strains S.c.1,S.c.3 and S.c.10 were selected as original strains for further higher production of chiral precursor R(-)-mandelic acid.The mutant strain S.c.10.2.8 possessing effective transforming ability and almost absolute enantioselectivity was obtained using ultraviolet and microwave mutagenesis.RESULTS Under the conditions of initial substrate concentration 20 mmol·L-1,pH 6.6,temperature 34 ℃,the yield and the enantiomeric excesses of R(-)-mandelic acid were 85% and 99% respectively.CONCLUSION Biotransformaton is a potential alternative method to produce chiral precursor R(-)-mandelic acid.
GUO Di-ping;XU Xio-ping;YNG Ki;LI Zhng-qin;PEI o-jun.
Study on Asymmetric Synthesis of Chiral Precursor R(-)-mandelic Acid [J]. Chinese Pharmaceutical Journal, 2007, 42(07): 550-553
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1］LILLY M. Advances in biotransformations processes[J］.Chem Eng Sci，1994， 49： 151-159.
[2］ZHANG Y B. Chiral Synthesis by Bio-Catalyst(生物催化的手性合成)[M］. Beijing：Chemical Industry Pres， 2001： 187.
[3］ZHU W Z， XU J H， YU J T. Asymmetry bioreduction of ethyl acetoacetate catalyzed by baker′s yeast [J］.J East China Uni Sci & Tech (华东理工大学学报)， 2000， 26(2)：154-156.
[4］YOU Q D， LIN G Q.Chiral Drugs(手性药物)[M］.Beijing：Chemical Industry Press， 2004： 120-138.
[5］HUANG L， DAI L X.Chemistry and Biology of Chiral Drugs (手性药物的化学与生物学)[M］. Beijing： Chemical Industry Press， 2004： 249-293.
[6］HEIDLAS J， ENGEL K H，TRESSL R. Enantioselectivities of Enzymes Involves in the reduction of methylketones by baker's yeast enzyme[J］.Microb Technol，1991，13(8)： 817-821.
[7］EGRI G， KOLBERT A， BALINT J， et al. Baker's yeast mediated stereoselec tive biotransformation of 1-acetoxy-3 aryloxypropane-2-ones [J］.Tetrahedron： Asymmestry，1998，9(2)：271-277.
